Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

That’s because certain genes play a role. Psoriasis is a skin disease that affects about 8 million Americans. It comes in several forms. Plaque psoriasis is the most common. Plaque psoriasis ...

Even though he suffers from psoriasis, Joel Thomas considers himself a lucky man. Psoriasis is a chronic skin disorder that affects over seven and a half million Americans. Many are not as lucky ...

J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...